CDC14B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.142400E-01
Normal-vs-Stage2
6.638000E-01
Normal-vs-Stage3
3.001800E-01
Normal-vs-Stage4
1.666610E-01
Stage1-vs-Stage2
7.055800E-01
Stage1-vs-Stage3
2.563900E-02
Stage1-vs-Stage4
1.596360E-01
Stage2-vs-Stage3
7.553900E-02
Stage2-vs-Stage4
6.737900E-02
Stage3-vs-Stage4
6.759100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.991600E-01
Normal-vs-AfricanAmerican
7.001800E-01
Normal-vs-Asian
5.790800E-01
Caucasian-vs-AfricanAmerican
8.729800E-01
Caucasian-vs-Asian
5.056600E-01
AfricanAmerican-vs-Asian
8.047600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.421800E-01
Normal-vs-Female
7.376800E-01
Male-vs-Female
4.672800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.565600E-01
Normal-vs-Age(41-60Yrs)
4.729200E-01
Normal-vs-Age(61-80Yrs)
7.816200E-01
Normal-vs-Age(81-100Yrs)
8.384600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.089400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.323000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.767000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.330160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.666600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.211000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.357200E-01
Normal-vs-Daily Drinker
9.923200E-01
Normal-vs-Weekly Drinker
8.142000E-01
Normal-vs-Occasional Drinker
5.207000E-01
Normal-vs-Social Drinker
6.675000E-01
Non Drinker-vs-Daily Drinker
7.012000E-01
Non Drinker-vs-Weekly Drinker
8.124400E-01
Non Drinker-vs-Occasional Drinker
3.963400E-01
Non Drinker-vs-Social Drinker
7.253400E-01
Daily Drinker-vs-Weekly Drinker
6.273800E-01
Daily Drinker-vs-Occasional Drinker
2.973200E-01
Daily Drinker-vs-Social Drinker
5.359000E-01
Weekly Drinker-vs-Occasional Drinker
7.943400E-01
Weekly Drinker-vs-Social Drinker
9.822800E-01
Occasional Drinker-vs-Social Drinker
6.361600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.284770E-01
Normal-vs-Grade 2
4.599900E-02
Normal-vs-Grade 3
6.137800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.156360E-01
Grade 1-vs-Grade 3
1.082170E-01
Grade 1-vs-Grade 4
1.284770E-01
Grade 2-vs-Grade 3
7.101800E-01
Grade 2-vs-Grade 4
4.599900E-02
Grade 3-vs-Grade 4
6.137800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.260000E-01
Normal-vs-NonDiabetic
6.795400E-01
Diabetic-vs-NonDiabetic
3.861800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.203000E-01
Normal-vs-NoPancreatitis
7.222000E-01
Pancreatitis-vs-NoPancreatitis
8.104600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.920400E-01
Normal-vs-N1
6.817000E-01
N0-vs-N1
9.252000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.745000E-01
Normal-vs-TP53-NonMutant
5.198400E-01
TP53-Mutant-vs-TP53-NonMutant
9.688200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
